glp 1 dexcom GLP-1 Diabetic Users Boost Stock: Analyzing the Impact Dexcom G4 Platinum

The delivery time for my 2nd order took so long and takes week for me to get

Accessed at www.nejm.org/doi/full/10.1056/NEJMoa2206038

Insurance companies therefore either elect to exclude GLP-1 drugs from their drug formulary, or create barriers to accessing them

nearly all efficacy evidence comes from animal or in vitro studies Fewer than 10 small human studies exist, none tracking use beyond about 12 weeks, so long-term safety (including cancer or fertility risk) is unknown Currently sits in a regulatory gray zone, complicating legitimate sourcing and quality assurance Side Effects: Most commonly reported issues are mild and short-lived: injection site soreness or reactions, occasional nausea, headache, and mild dizziness, typically resolving within hours to days